Quantitative ultrasound (QUS) of bone in the management of postmenopausal women

Maturitas

Volumn 47, Issue 2, 2004, Pages 139-149

  Gambacciani, Marco ^a   De Aloysio, Domenico ^b   Elia, David ^c   Van Der Mooren, Marius J ^d   Hadji, Peyman ^e   Wüster, Christian ^f  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Menopause Centres MG FMP   (France)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aging; Menopause; Osteoporosis; Ultrasound

Indexed keywords

BONE EXAMINATION; CLIMACTERIUM; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; INCIDENCE; LIFE EXPECTANCY; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; RISK FACTOR; SECONDARY OSTEOPOROSIS;

EID: 1642481300     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00245-7     Document Type: Article

References (58)

1. WHO Study Group, In: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series: 843, 1994.
2. Slemenda C., Hui S.L., Longcope C., Johnston C.C. Sex steroids and bone mass: a study of changes about the time of menopause. J. Clin. Invest. 80:1987;1261-1269.
3. Riggs B.L., Wahner H.W., Dunn W.L., Mazess R.B., Offord K.P., Melton L.J. III. Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J. Clin. Invest. 67:1981;328-335.
4. Noteloviz M. Osteoporosis: screening, prevention, and management. Fertil. Steril. 59:1993;707-725.
5. Nilas L., Christiansen C. The pathophysiology of peri and postmenopausal bone loss. Br. J. Obstet. Gynaecol. 96:1989;580-587.
6. Gambacciani M., Spinetti A., de Simone L., et al. The relative contributions of menopause and aging to postmenopausal vertebral osteopenia. J. Clin. Endocrinol. Metab. 77:(5):1993;1148-1151.
7. Gambacciani M., Spinetti A., De Simone L., et al. Postmenopausal bone loss of the proximal femur: estimated contribution of menopause and aging. Menopause. 2:1995;169-174.
8. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-50.
9. Kanis J.A., Gluer C.C. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int. 11:2000;192-202.
10. Siris E.S., Miller P.D., Barrett-Connor E., Faulkner K.G., et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. J. Am. Med. Assoc. 286:(22):2001;2815-2821.
11. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group. Lancet. 348:1996;1535-1541.
12. Ettinger B., Black D.M., Mitlak B., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. J. Am. Med. Assoc. 282:1999;637-645.
13. Langton C.M., Palmer S.D., Porter R.W. The measurement of broadband ultrasonic attenuation in cancellous bone. Engl. Med. 13:1984;89-91.
14. Glüer C.C. Quantitative ultrasound technique for the assessment of osteoporosis: expert agreement on current status. J. Bone Miner. Res. 12:1997;1280-1288.
15. Hans D., Dargent-Molina P., Schott A.M., et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet. 348:1996;511-514.
16. Bauer D.C., Glüer C.C., Cauley J.A., et al. Bone ultrasound predicts fractures strongly and independently of densitometry in older women: a prospective study. Arch. Intern. Med. 157:1997;629-634.
17. Hans D., Fuerst T., Lang T., et al. How can we measure bone quality. Bailliere's Clin. Rheumatol. 11:(3):1997;495-515.
18. Sili Scavalli A., Marini M., Spadaro A., et al. Ultrasound transmission velocity of the proximal phalanxes of the non-dominant hand in the study of osteoporosis. Clin. Rheumatol. 16:(4):1997;396-403.
19. National Osteoporosis Society. The use of quantitative ultrasound in the management of osteoporosis in primary or secondary care. 1988 (position statement of 30th June 1998).
20. Gambacciani M., Spinetti A., Gallo R., Cappagli B., Teti G.C., Facchini V. Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation. Am. J. Obstet. Gynecol. 173:1995;890-893.
21. Rubin C.T., Pratt G.W., Porter A.L. The use of ultrasound in vivo to determine acute change in mechanical properties of bone following intense physical activity. J. Biomech. 20:1987;723-727.
22. Cepollaro C., Agnusdei D., Gonnelli S., et al. Ultrasonographic assessment of bone in normal Italian males and females. Br. J. Radiol. 68:1995;910-914.
23. Gambacciani M., Benussi C., Cappagli B., Ciaponi M., Genazzani A.R. Quantitative bone ultrasound in climacteric women. J. Clin. Densitom. 3:1998;303-308.
24. Ventura V., Mauloni M., Mura M., Paltrinieri F., de Aloysio D. Ultrasound velocity changes at the proximal phalanxes of the hand in pre-, peri- and postmenopausal women. Osteoporosis Int. 6:1996;368-375.
25. Murgia C., Cagnacci A., Paoletti A.M., Pilia I., Meloni A., Melis G.B. Comparison between a new ultrasound densitometer and single-photon absorptiometry. Menopause. 3:1996;149-153.
26. Baran D.T. Quantitative ultrasound: a technique to target women with low bone mass for preventive therapy. Am. J. Med. 98:1995;48S-51S.
27. De Aloysio D., Rovati L.C., Cadossi R., et al. Bone effects of transdermal hormone replacement therapy in postmenopausal women as evaluated by means of ultrasound: an open one year prospective study. Maturitas. 27:1997;61-68.
28. Mautalen C., Vega E., Gonzales D., Carrilero P., Otano A., Silberman F. Ultrasound and dual X-ray absorptiometry densitometry in women with hip fracture. Calcif. Tissue Int. 57:1995;165-168.
29. Faulkner K.G., McClung M.R., Coleman L.J., Kingston-Sandahl E. Quantiative ultrasound of the heel: correlation with densitometric measurements at different skeletal sites. Osteoporosis Int. 4:1994;42-47.
30. Gonnelli S., Cepollaro C., Agnusdei D., Palmieri R., Rossi S., Gennari C. Diagnostic value of ultrasound analysis and bone densitometry as predictors of vertebral deformity in postmenopausal women. Osteoporosis Int. 5:1995;413-418.
31. Baran D.T., Kelley A.M., Karellas A., et al. Ultrasound attenuation of the os calcis in women with osteoporosis and hip fractures. Calcif. Tissue Int. 43:1988;138-142.
32. Gregg E.W., Kriska A.M., Salamone L.M., et al. The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporosis Int. 7:(2):1997;89-99.
33. Hadji P., Hars O., Beckmann M.W., et al. Age changes of calcaneal ultrasound in healthy German women. Calcif. Tissue Int. 65:1999;117-120.
34. Hadji P., Wüster C., Hars O., et al. The influence of long-term non-suppressive levothyroxine treatment on ultrasound of bone in women. Eur. J. Endocrinol. 142:(5):2000;445-450.
35. Hadji P, Meyer-Wittkopf M, Kalder M, et al. Age-associated changes in bone ultrasound of the os calcis. Expanded data in healthy German women. J Clin Densitom, 2002;5(3):297-303.
36. Hadji P., Jäckel C., Hars O., et al. Bone mass in women with breast cancer. J. Bone Miner. Res. 14:(1):1999;202.
37. Benitez C.L., Schneider D.L., Barrett-Connor E., Sartoris D.J. Hand ultrasound for osteoporosis screening in postmenopausal women. Osteoporosis Int. 11:2000;203-210.
38. National Osteoporosis Society. The use of quantitative ultrasound in the management of osteoporosis (position statement of 31th January 2002).
39. Machado A.B.C., Ingle B.M., Eastell R. Monitoring alendronate therapy with QUS and dual X-ray absorptiometry (DXA). J. Bone Miner. Res. 14:(1):1999;U377.
40. Hadji P., Bock K., Wüster C., et al. Effect of hormone replacement therapy on ultrasonometric heel measurement. Am. J. Obstet. Gynecol. 182:2000;529-534.
41. Gonnelli S., Cepollaro C., Montagnani A., et al. Heel ultrasonography in monitoring alendronate therapy: a 4-year longitudinal study. Osteoporosis Int. 13:2002;415-421.
42. Mauloni M., Rovati L.C., Cadossi R., de Terlizzi F., Ventura V., de Aloysio D. Monitoring bone effect of transdermal hormone replacement therapy by ultrasound investigation at the phalanx. A 4-year follow up study. Menopause. 7:2000;402-412.
43. Giorgino R., Lorusso D., Paparella P. Ultrasound bone densitometry and 2-year hormonal replacement therapy efficacy in the prevention of early postmenopausal bone loss. Osteoporosis Int. 6:(Suppl. 1):1996;S341.
44. Njeh C.F., Hans D., Fuerst T., Gluer C.C., Genant H.K. Quantitative ultrasound: assessment of osteoporosis and bone. 1999;47-73 Status, Martin Duniz Ltd, London, UK.
45. Hadji P., Hars O., Wüster C., et al. Stiffness index identifies patients with osteoporotic fracture better than ultrasound velocity or attenuation alone. Maturitas. 31:1999;221-226.
46. Hans D., Njeh C.F., Genant H.K., Meunier P.J. Quantitative ultrasound in bone status assessment. Rev. Rhum. 65:1998;7-9.
47. de Terlizzi F., Battista S., Cavani F., Canè V., Cadossi R. Influence of bone tissue density and elasticity on ultrasound propagation: an in vitro study. J. Bone Miner. Res. 15:2000;2458-2466.
48. Hans D., Wu C., Njeh C.F., et al. Ultrasound velocity of trabecular bones reflects mainly bone density and elasticity. Calcif. Tissue Int. 64:1999;18-23.
49. Glüer C.-C., Wu C.Y., Jergas M., Goldstein S.A., Genant H.K. Three quantitative ultrasound parameters reflect bone structure. Calcif. Tissue Int. 55:1994;46-52.
50. Wüster C., Albanese C., de Aloysio D., et al. Phalangeal osteosonogrammetry study (PhOS): age related changes, diagnostic sensitivity and discrimination power. J. Bone Miner. Res. 15:2000;1603-1614.
51. Buckwalter J.A., Glimcher M.J., Cooper R.R., Recker R. Bone biology. J. Bone Jt. Surg. 77-A:1995;1256-1289.
52. Barkmann R., Kantorovich E., Singal C., et al. A new method for quantitative ultrasound measurements at multiple skeletal sites. J. Clin. Densitom. 3:2000;1-7.
53. Mele R., Masci G., Ventura V., de Aloysio D., Bicocchi M., Cadossi R. Three-year longitudinal study with quantitative ultrasound at the hand phalanx in a female population. Osteoporosis Int. 7:1997;550-557.
54. Hartl F., Tyndall A., Kraenzlin M., et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: result of the Basel Osteoporosis Study. J. Bone Miner. Res. 17:2002;321-330.
55. Gonnelli S., Cepollaro C., Pondrelli C. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study. Osteoporosis Int. 6:1996;303-307.
56. Gonnelli S., Cepollaro C., Pondrelli C. Ultrasound parameters in the follow-up of osteoporotic women treated with oestrogen. J. Clin. Densitom. 1:(Suppl.):1998;97.
57. Mauloni M., Ventura V., de Aloysio D., et al. Multicenter Italian study on the bone mass ultrasonographic evaluation at the phalanges in the climacteric (VUMOF-CLIFE). It. J. Miner. Electrol. Metab. 14:2000;23-26.
58. Gambacciani M, Donati Sarti C. Phalangeal quantitative ultrasonography at climacteric in the Italian menopause project. F-25-04 10th World congress on the menopause, Berlin, Germany, 2002.